Trial NCT04651790
Publication Abarca K, medRxiv, 2022
Primary outcome on the report: 1. Frequency of AE occurring on the first 7 days after each dose of the vaccine in each vaccination schedule; 2. Confirmed SARS-CoV-2 infection of two vaccination schedules, starting two weeks after the second dose.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.